- Motley Fool
Have Gilead's Gains Evaporated in the Coronavirus Treatment Race?
Gilead Sciences (NASDAQ: GILD) started the year strong. As a result, while the rest of the stock market slid, Gilead did just the opposite. To make matters worse, the World Health Organization (WHO) recently advised against using remdesivir as a treatment for COVID-19.
- The Independent
Black Friday deals 2020: Best offers from Boots, Currys, Nintendo and more
The weekend of the year’s best shopping event is finally here, and these are the best deals to shop now
- Motley Fool
Just in Time for Christmas, Roblox Files to IPO
As recently as February, Roblox closed a round of venture capital funding that valued the online videogame hub at just $4 billion. If you haven't heard of Roblox, your children will probably be your best resource to explain "what it is." Popular games that kids play on Roblox include such titles as Natural Disaster Survival (where one attempts to, er, survive natural disasters), Hide and Seek Extreme (self-explanatory), and Adopt Me!
Headlines
- Ohio State vs. Illinois canceled after coach Ryan Day's positive virus test
- Ian Book, defense carry No. 2 Notre Dame past No. 19 North Carolina
- NFL orders teams to shut down all in-person activities on Monday and Tuesday
- Mickelson carries Barkley to victory over Manning, Curry in The Match, part 3
- Great deals on sports apparel, workout equipment and more for Black Friday
Golf
Sea Island, GA
| Thru | Total | Purse | ||
|---|---|---|---|---|
| 2 | -19 | $1,188,000 | ||
| 2 | -19 | $719,400 | ||
| F | -18 | $455,400 | ||
| F | -17 | $297,000 | ||
| F | -17 | $297,000 | ||
| F | -16 | $215,325 | ||
| F | -16 | $215,325 | ||
| F | -16 | $215,325 | ||
| F | -16 | $215,325 | ||
| F | -15 | $173,250 |